Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real‐life study-Reference-Cited by-同舟云学术

Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real‐life study

Published:2021-06-20 Issue:2 Volume:194 Page:336-343
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Comont Thibault¹,Meunier Mathieu²,Cherait Amina³,Santana Clemence⁴,Cluzeau Thomas⁵,Slama Bohrane⁶,Laribi Kamel⁷^ORCID,Giraud Jean‐Thomas⁸,Dimicoli Sophie⁹,Berceanu Ana¹⁰,Le Clech Lenaïg¹¹,Cony‐Makhoul Pascale¹²^ORCID,Gruson Berangere¹³,Torregrosa Jose¹⁴,Sanhes Laurence¹⁵,Jachiet Vincent¹⁶^ORCID,Azerad Marie‐Agnes¹⁷,Al Jijakli Ahmad¹⁸,Gyan Emmanuel¹⁹,Gaudin Clement²⁰,Broner Jonathan²¹,Guerveno Claire²²,Guillaume Thierry²³^ORCID,Ades Pr Lionel³,Beyne‐Rauzy Odile¹,Fenaux Pierre³^ORCID,

Affiliation:

1. Service de Médecine Interne IUCT OncopoleCentre Hospitalier Universitaire de Toulouse ToulouseFrance

2. CHU Grenoble Alpes Université Grenoble AlpesInstitute for Advanced Biosciences, INSERM U1209CNRSUMR 5309 GrenobleFrance

3. Service d’Hématologie Sénior Hôpital Saint‐LouisAssistance Publique Hôpitaux de Paris (APHP)Université de Paris ParisFrance

4. Service d’Hématologie Centre Léon Bérard LyonFrance

5. Service d’Hématologie Clinique CHU de Nice NiceFrance

6. Service d’onco‐hématologie Centre Hospitalier Général d’Avignon AvignonFrance

7. Service d’Hématologie Centre Hospitalier Le Mans Le MansFrance

8. Service de Médecine Interne Centre Hospitalier de Tarbes TarbesFrance

9. Service d’Hématologie Centre Hospitalier Universitaire de Bordeaux BordeauxFrance

10. Service d’Hématologie Centre Hospitalier Universitaire de Besançon BesançonFrance

11. Service d’Hématologie Centre Hospitalier de Quimper QuimperFrance

12. Service d’Hématologie Centre Hospitalier d’Annecy Genevois PringyFrance

13. Service d’Hématologie Centre Hospitalier Universitaire d’Amiens AmiensFrance

14. Service d’Hématologie et Thérapie Cellulaire Centre Hospitalier Universitaire de Poitiers PoitiersFrance

15. Service d’Hématologie Centre Hospitalier de Perpignan PerpignanFrance

16. Service de Médecine Interne Hôpital Saint‐AntoineAP‐HP Paris France

17. Service d’Hématologie Centre Hospitalier Universitaire de Liège Liège Belgique

18. Service d’Hématologie Centre Hospitalier d’Argenteuil ArgenteuilFrance

19. Service d’Hématologie et Thérapie Cellulaire Centre Hospitalier Universitaire de Tours ToursFrance

20. Service de Médecine Interne‐Oncogériatrie Hôpital PurpanCentre Hospitalier Universitaire de Toulouse ToulouseFrance

21. Service de Médecine Interne Centre Hospitalier Universitaire de Nîmes NîmesFrance

22. Service de Médecine Interne Centre Hospitalier d’Albi AlbiFrance

23. Service d’Hématologie Centre Hospitalier Universitaire de Nantes Nantes France

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17539

Reference30 articles.

1. Myelodysplastic Syndromes

2. Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults

3. Revised International Prognostic Scoring System for Myelodysplastic Syndromes

4. Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management

5. Low incidence of specific anti‐platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eltrombopag in chronic myelomonocytic leukemia with severe thrombocytopenia. A Groupe Francophone des Myélodysplasies (GFM) study;Leukemia;2024-09-12

2. Eltrombopag in Chronic Myelomonocytic Leukemia With Severe Thrombocytopenia. A Gfm Study;2024-03-21

3. Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS);Journal of Clinical Oncology;2023-10-01

4. Eltrombopag in Lower-Risk Myelodysplastic Syndrome: Revival of Its Use in Thrombocytopenia;Journal of Clinical Oncology;2023-10-01

5. Use of steroids in the management of low-risk myelodysplastic syndromes with autoimmune features;BLOOD TRANSFUS-ITALY;2023